TransMedics [TMDX] vs Boston Scientific [BSX] Detailed Stock Comparison
TransMedics
NASDAQ
Loading...
Boston Scientific
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: TransMedics wins in 10 metrics, Boston Scientific wins in 9 metrics, with 0 ties. TransMedics appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | TransMedics | Boston Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 59.92 | 61.76 | TransMedics |
| Price-to-Book Ratio | 12.76 | 6.85 | Boston Scientific |
| Debt-to-Equity Ratio | 163.10 | 53.09 | Boston Scientific |
| PEG Ratio | 0.34 | 0.42 | TransMedics |
| EV/EBITDA | 42.88 | 34.95 | Boston Scientific |
| Profit Margin (TTM) | 13.49% | 13.55% | Boston Scientific |
| Operating Margin (TTM) | 23.24% | 18.63% | TransMedics |
| EBITDA Margin (TTM) | 23.24% | 18.63% | TransMedics |
| Return on Equity | 28.21% | 11.55% | TransMedics |
| Return on Assets (TTM) | 5.80% | 5.39% | TransMedics |
| Free Cash Flow (TTM) | $-80.94M | $2.37B | Boston Scientific |
| 1-Year Return | -32.36% | 32.89% | Boston Scientific |
| Price-to-Sales Ratio (TTM) | 7.65 | 8.31 | TransMedics |
| Enterprise Value | $4.30B | $164.42B | Boston Scientific |
| EV/Revenue Ratio | 8.09 | 8.89 | TransMedics |
| Gross Profit Margin (TTM) | 61.38% | 67.65% | Boston Scientific |
| Revenue per Share (TTM) | $16 | $13 | TransMedics |
| Earnings per Share (Diluted) | $1.99 | $1.68 | TransMedics |
| Beta (Stock Volatility) | 2.09 | 0.66 | Boston Scientific |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
TransMedics vs Boston Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| TransMedics | -2.52% | -8.42% | 14.67% | -2.06% | 65.13% | 78.66% |
| Boston Scientific | -0.79% | 1.02% | 1.38% | 0.54% | 0.69% | 17.71% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| TransMedics | -32.36% | 127.30% | 568.22% | 379.07% | 379.07% | 379.07% |
| Boston Scientific | 32.89% | 159.65% | 156.42% | 516.34% | 1,816.39% | 301.11% |
Performance & Financial Health Analysis: TransMedics vs Boston Scientific
| Metric | TMDX | BSX |
|---|---|---|
| Market Information | ||
| Market Cap | $4.07B | $153.73B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 866,924 | 6,087,580 |
| 90 Day Avg. Volume | 1,217,355 | 7,069,760 |
| Last Close | $118.81 | $105.21 |
| 52 Week Range | $55.00 - $177.37 | $78.30 - $108.94 |
| % from 52W High | -33.02% | -3.42% |
| All-Time High | $177.37 (Aug 19, 2024) | $108.94 (Jul 23, 2025) |
| % from All-Time High | -33.02% | -3.42% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.38% | 0.23% |
| Quarterly Earnings Growth | 1.86% | 1.46% |
| Financial Health | ||
| Profit Margin (TTM) | 0.13% | 0.14% |
| Operating Margin (TTM) | 0.23% | 0.19% |
| Return on Equity (TTM) | 0.28% | 0.12% |
| Debt to Equity (MRQ) | 163.10 | 53.09 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $9.35 | $15.14 |
| Cash per Share (MRQ) | $11.75 | $0.36 |
| Operating Cash Flow (TTM) | $115.27M | $4.28B |
| Levered Free Cash Flow (TTM) | $-7,754,500 | $2.94B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: TransMedics vs Boston Scientific
| Metric | TMDX | BSX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 59.92 | 61.76 |
| Forward P/E | 72.27 | 37.19 |
| PEG Ratio | 0.34 | 0.42 |
| Price to Sales (TTM) | 7.65 | 8.31 |
| Price to Book (MRQ) | 12.76 | 6.85 |
| Market Capitalization | ||
| Market Capitalization | $4.07B | $153.73B |
| Enterprise Value | $4.30B | $164.42B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.09 | 8.89 |
| Enterprise to EBITDA | 42.88 | 34.95 |
| Risk & Other Metrics | ||
| Beta | 2.09 | 0.66 |
| Book Value per Share (MRQ) | $9.35 | $15.14 |
Financial Statements Comparison: TransMedics vs Boston Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TMDX | BSX |
|---|---|---|
| Revenue/Sales | $143.54M | $4.66B |
| Cost of Goods Sold | $55.31M | $1.45B |
| Gross Profit | $88.23M | $3.21B |
| Research & Development | $17.16M | $443.00M |
| Operating Income (EBIT) | $27.44M | $937.00M |
| EBITDA | $36.27M | $1.23B |
| Pre-Tax Income | $26.68M | $805.00M |
| Income Tax | $994,000 | $133.00M |
| Net Income (Profit) | $25.68M | $672.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TMDX | BSX |
|---|---|---|
| Cash & Equivalents | $310.14M | $725.00M |
| Total Current Assets | $505.92M | $7.34B |
| Total Current Liabilities | $55.60M | $5.06B |
| Long-Term Debt | $515.62M | $10.93B |
| Total Shareholders Equity | $266.31M | $22.45B |
| Retained Earnings | $-442.56M | $3.35B |
| Property, Plant & Equipment | $40.54M | $448.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TMDX | BSX |
|---|---|---|
| Operating Cash Flow | $354,000 | $513.00M |
| Capital Expenditures | $-27.04M | $-187.00M |
| Free Cash Flow | $-29.89M | $277.00M |
| Debt Repayment | N/A | $-1.31B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TMDX | BSX |
|---|---|---|
| Shares Short | 7.67M | 16.27M |
| Short Ratio | 6.69 | 2.15 |
| Short % of Float | 0.39% | 0.01% |
| Average Daily Volume (10 Day) | 866,924 | 6,087,580 |
| Average Daily Volume (90 Day) | 1,217,355 | 7,069,760 |
| Shares Outstanding | 33.62M | 1.47B |
| Float Shares | 32.96M | 1.48B |
| % Held by Insiders | 0.03% | 0.00% |
| % Held by Institutions | 1.13% | 0.94% |
Dividend Analysis & Yield Comparison: TransMedics vs Boston Scientific
| Metric | TMDX | BSX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |